Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ABIO

ARCA Biopharma (ABIO)

ARCA Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABIO
DateTimeSourceHeadlineSymbolCompany
07/22/20245:17PMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:ABIOARCA Biopharma Inc
07/12/20247:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
07/12/20247:10PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
07/09/20245:29PMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:ABIOARCA Biopharma Inc
07/09/20245:04PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ABIOARCA Biopharma Inc
07/09/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
07/05/20245:20PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ABIOARCA Biopharma Inc
06/18/20245:17PMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:ABIOARCA Biopharma Inc
06/06/20244:45PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ABIOARCA Biopharma Inc
05/22/20243:08PMPR Newswire (US)Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
04/25/20244:15PMGlobeNewswire Inc.ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
04/05/20241:09PMPR Newswire (US)Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
04/03/20247:30AMGlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
04/03/20247:30AMGlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
02/07/20241:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABIOARCA Biopharma Inc
02/06/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
02/01/20244:39PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
02/01/20244:35PMGlobeNewswire Inc.ARCA biopharma Announces 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
02/01/20244:15PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABIOARCA Biopharma Inc
01/31/20246:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
12/19/20234:25PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ABIOARCA Biopharma Inc
12/19/20234:20PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ABIOARCA Biopharma Inc
12/19/20234:15PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABIOARCA Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABIO